Latest News about GKOS
Recent news which mentions GKOS
Glaukos Corp (GKOS) Q4 2020 Earnings Call Transcript
February 26, 2021
Tickers
GKOS
From Motley Fool
The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida
February 26, 2021
From Benzinga
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
February 25, 2021
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
February 20, 2021
From Benzinga
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
February 11, 2021
From Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
From Benzinga
The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street
February 05, 2021
From Benzinga
The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs
February 04, 2021
From Benzinga
The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision
February 03, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
February 02, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 29, 2021
January 29, 2021
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO
January 29, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 28, 2021
From Benzinga
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
From Benzinga
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
January 14, 2021
From Benzinga
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
January 08, 2021
From Benzinga
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
January 07, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 22, 2020
From Benzinga
The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data
December 18, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
December 17, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
December 16, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For December 9, 2020
December 09, 2020
From Benzinga
The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs
December 04, 2020
From Benzinga
Benzinga's Top Upgrades, Downgrades For October 8, 2020
October 08, 2020
From Benzinga
3 Top Mid-Cap Stocks to Buy Right Now
September 24, 2020
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.